 Functional character augmentation lymphocytes regional lymph nodes patients lung cancer lymph node metastases frequent lung cancer cancers impaired defensive mechanisms regional lymph nodes little immunologic function regional lymph node lymphocytes RLNL patients lung cancer immunologic properties RLNL comparison peripheral blood lymphocytes PBL natural killer NK cell activity RLNL PBL patients lung cancer NK activity depressed RLNL PBL contrast production RLNL PBL cytotoxic effect RLNL nonmetastatic lymph nodes target cells cells cells NK-resistant human lung cancer adenocarcinoma epidermoid carcinoma vitro incubation recombinant biologic response modifier inducer cytotoxicity RLNL effector cells lymphokine-activated killer LAK cells depletion lymphocyte subsets pretreatment specific monoclonal antibody LAK activity RLNL cells lymphocyte subsets LAK activity PBL cells majority effector cells RLNL LAK cells cytotoxic cell population